EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2019–2020

Jesse Fryk, Hazel Clothier, Daneeta Hennessy, Georgina Lewis, Emma Roney, Nigel Crawford, Jim Buttery

Communicable Diseases Intelligence · 2026

DOI: 10.33321/cdi.2026.50.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Communicable Diseases Intelligence, 2026. Verfasst von Jesse Fryk und 6 weiteren Autor:innen. Beteiligte Einrichtung: SAEFVIC, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Epidemiology-Informatics, Centre for Health Analytics, Melbourne Chil…. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Vaccination, Vaccines. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BackgroundAdverse event following immunisation (AEFI) surveillance in Victoria is conducted through Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC), an enhanced surveillance system integrated with clinical services for vaccinees experiencing an AEFI. This report summarises SAEFVIC’s surveillance and vaccine pharmacovigilance activities in 2019 and 2020. MethodsA retrospective cohort study approach was used to analyse AEFI reports submitted in 2019 and 2020, compared to those since 2015. Data were categorised by vaccinee demographics (age; sex; pregnancy; and Indigenous status), vaccines administered and reported AEFI. Age cohorts were defined as best fit to the National Immunisation Program age groups. Proportional reporting ratio was determined for perceived signals being investigated. Clinical services and educational activities were described. ResultsThere were 3,828 AEFI reports received in 2019 and 2020 (28.8 per 100,000 population), with 7.6% defined as serious; 52% of all reports were female vaccinees; 56 of 464 reports among adult females (12.1%) were pregnant vaccinees; and 29 reports (0.9%) were Indigenous Australians. Reporting trends by age group were similar across all cohorts. No vaccine safety signals were confirmed. Telehealth consultations at Specialist Immunisation Clinics increased in 2020 in-line with Medicare eligibility criteria changes. Educational resources on various vaccine safety topics were published, particularly the anticipated coronavirus disease 2019 (COVID-19) vaccination program. ConclusionAEFI surveillance in Victoria continues to be robust through the SAEFVIC model and provides confidence in informing the safety profile of vaccines administered in Australia. These data provide a baseline for AEFI surveillance for comparison to the COVID-19 vaccination program commenced in 2021.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsVaccinationVaccinesHumansFemaleRetrospective StudiesAdultMaleVictoriaInfantAdolescentYoung AdultChild, PreschoolMiddle AgedChildAgedPharmacovigilanceInfant, NewbornPregnancyCOVID-19

Stichwörter der Autor:innen

adverse eventsimmunisationpharmacovigilancepost-licensuresurveillancevaccine safety

Substanzen

Vaccines

Autor:innen und Institutionen

  • SAEFVIC, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Epidemiology-Informatics, Centre for Health Analytics, Melbourne Children's Campus, Melbourne, Victoria, Australia.
  • SAEFVIC, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Epidemiology-Informatics, Centre for Health Analytics, Melbourne Children's Campus, Melbourne, Victoria, Australia; School of Population an…
  • SAEFVIC, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Epidemiology-Informatics, Centre for Health Analytics, Melbourne Children's Campus, Melbourne, Victoria, Australia. daneeta.hennessy@mcri.e…
  • SAEFVIC, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • SAEFVIC, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Department Paediatrics, University of Melbourne, Parkville, Victoria, Australia; Immunisation Service, Royal Children's Hospital, Parkville…
  • SAEFVIC, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Epidemiology-Informatics, Centre for Health Analytics, Melbourne Children's Campus, Melbourne, Victoria, Australia; Department Paediatrics,…

Zitieren

APA

Fryk, J., Clothier, H., Hennessy, D., Lewis, G., Roney, E., Crawford, N., & Buttery, J. (2026). SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2019–2020. Communicable Diseases Intelligence. https://doi.org/10.33321/cdi.2026.50.012

Vancouver

Fryk J, Clothier H, Hennessy D, Lewis G, Roney E, Crawford N, et al. SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2019–2020. Communicable Diseases Intelligence. 2026. doi:10.33321/cdi.2026.50.012

BibTeX
@article{Fryk2026,
  author = {Fryk, Jesse and Clothier, Hazel and Hennessy, Daneeta and Lewis, Georgina and Roney, Emma and Crawford, Nigel and Buttery, Jim},
  title = {SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2019–2020},
  journal = {Communicable Diseases Intelligence},
  year = {2026},
  doi = {10.33321/cdi.2026.50.012}
}
Kostenlos starten →